NEW YORK (GenomeWeb News) — PerkinElmer today said its neonatal screening technology will help expand a screening program in The Netherlands.

 

The company said it will provide four tandem mass spec systems, reagents, and software to support the nation’s five hospital screening centers.

 

The partnership will enable the country to screen for 14 disorders compared with three disorders.

Financial terms of the alliance were not disclosed.